![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
NICE has existed for 10 years. During this period, its methodological approach to developing guidance and assessing the value (cost–effectiveness) of healthcare interventions has received considerable national and international interest. At the same time, individual decisions have generated enormous controversy. This 10th anniversary provides an opportunity to look back at how the institute has responded and adapted to the various challenges and controversies. Following Lord Darzi’s review of the National Health Service (UK) in 2008, the institute took on further responsibilities for setting clinical standards for the National Health Service. This article explores these developments and speculates on future trends.
Financial & competing interests disclosure
Peter Littlejohns is an employee of NICE. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.